The Cost-Effectiveness of Congenital Adrenal Hyperplasia Newborn Screening in Brazil: A Comparison Between Screened and Unscreened Cohorts

Background: Newborn screening for congenital adrenal hyperplasia (CAH-NBS) is not yet a worldwide consensus, in part due to inconclusive evidence regarding cost-effectiveness because the analysis requires an understanding of the short- and long-term costs of care associated with delayed diagnosis. O...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pediatr
Main Authors: de Miranda, Mirela Costa, Haddad, Luciana Bertocco de Paiva, Trindade, Evelinda, Cassenote, Alex, Hayashi, Giselle Y., Damiani, Durval, Costa, Fernanda Cavalieri, Madureira, Guiomar, de Mendonca, Berenice Bilharinho, Bachega, Tania A. S. S.
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Pediatrics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8183606/
https://ncbi.nlm.nih.gov/pubmed/34109139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fped.2021.659492
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados